Article ; Online: Direct-to-Consumer Telemedicine.
The journal of allergy and clinical immunology. In practice
2019 Volume 7, Issue 8, Page(s) 2546–2552
Abstract: The telemedicine industry and adoption of services have grown exponentially in the last 5 years, and the market is expected to reach more than $130 billion by 2025. Most US health institutions and hospital systems are currently using some form of ... ...
| Abstract | The telemedicine industry and adoption of services have grown exponentially in the last 5 years, and the market is expected to reach more than $130 billion by 2025. Most US health institutions and hospital systems are currently using some form of telehealth, and more than 90% of health care executives surveyed across the United States have virtual care on their roadmap for growth. Telemedicine has been proposed as a way to expand the reach of allergy services and allow more patients to manage their disease with an allergy specialist. Technology can help address fragmentation of allergy care, which is currently provided in multiple clinical settings beyond the allergist's office including in primary care, pulmonary, dermatology, ear, nose, and throat, urgent care, and the emergency room. Remote monitoring, specialist second opinions, and synchronous and asynchronous encounters offer opportunities to streamline routine care, especially as smart hardware such as digital inhalers hit the market and reimbursement for telehealth services evolve. To date, allergy care has been a significant area of interest for direct-to-consumer telemedicine solutions, although the care has mainly been offered by nonallergists. Quality assurance and adherence to evidence-based standards, particularly in the self-pay direct-to-consumer space, warrant attention. |
|---|---|
| MeSH term(s) | Delivery of Health Care/statistics & numerical data ; Evidence-Based Practice ; Humans ; Hypersensitivity/epidemiology ; Monitoring, Physiologic ; Quality Assurance, Health Care ; Telemedicine/statistics & numerical data ; United States/epidemiology |
| Language | English |
| Publishing date | 2019-11-06 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 2843237-X |
| ISSN | 2213-2201 ; 2213-2198 |
| ISSN (online) | 2213-2201 |
| ISSN | 2213-2198 |
| DOI | 10.1016/j.jaip.2019.06.027 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 7086: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.